{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:12:13Z","timestamp":1697274733731},"reference-count":35,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T00:00:00Z","timestamp":1250812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Data suggest that esomeprazole decreases gastric secretion.<\/jats:p><jats:p><jats:bold>Aims\u2002<\/jats:bold> To assess the effect of a single i.v. esomeprazole dose on gastric secretion volume 3\u2003h after drug administration, as a primary endpoint, and to evaluate, as secondary endpoints, the reduction 1 and 5\u2003h after dosing; time when the gastric pH was &lt;2.5 and esomeprazole\u2019s safety.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> In all, 23 healthy <jats:italic>Helicobacter pylori<\/jats:italic>\u2010negative volunteers (10 men, 13 women, mean age 28.2\u2003\u00b1\u20036) participated in this single\u2010centre, randomized, double\u2010blind, placebo\u2010controlled, 2\u2010way, single\u2010dose cross\u2010over study. In different sessions, volunteers received i.v. either esomeprazole 40\u2003mg or placebo. An inserted double\u2010lumen nasogastric tube perfused and aspirated gastric liquid. Mechanical fractioned aspiration measured secretion volume; aliquot spectrophotometry assessed gastric secretion volume lost to the duodenum.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Three hours post\u2010i.v. esomeprazole, average gastric secretion decreased by 77.6% (vs. baseline) compared to placebo. Values 1 and 5\u2003h after dosing were 73.5% and 74.5%. Five hours after esomeprazole, the gastric pH was &lt;2.5 3.9% of the time and 73.3% after placebo (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.002). Esomeprazole was well\u2010tolerated. No serious adverse events occurred.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Intravenous esomeprazole decreases gastric secretions. The potential clinical impact in averting bronchoaspiration during anaesthesia induction and in intensive care patients should be investigated in further studies.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04128.x","type":"journal-article","created":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T14:51:49Z","timestamp":1250866309000},"page":"1022-1029","source":"Crossref","is-referenced-by-count":0,"title":["A single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteers"],"prefix":"10.1111","volume":"30","author":[{"given":"C.","family":"NICHITA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.\u2010W.","family":"ABDOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"MAERTEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"HERRANZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"MOURET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"THALMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F.","family":"MICHETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"DORTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02943.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01168.x"},{"key":"e_1_2_6_4_2","first-page":"654","article-title":"Effect of intravenous esomeprazole 40\u2003mg and pantoprazole 40\u2003mg on gastric pH in healthy subjects A prospective, open, randomised, two\u2010way cross over comparative study","volume":"57","author":"Piccoli F","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.meg.0000252628.57925.32"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02339.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03074.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP45345"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199604000-00027"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200003000-00038"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000086895.64140.B3"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/bja\/76.4.567","article-title":"Comparison of the effect of two dose schedules of oral omeprazole with oral ranitidine on gastric aspirate pH and volume in patients undergoing elective surgery","volume":"76","author":"Levack ID","year":"1996","journal-title":"Br J Anaesth"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0445-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03011682"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03947.x"},{"key":"e_1_2_6_16_2","first-page":"402","article-title":"Gastric reflux and pulmonary aspiration in anaesthesia","volume":"69","author":"Smith G","year":"2003","journal-title":"Minerva Anaesthesiol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/69.4.404"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08783.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0804-6"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.4.468"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/00365529708996515","article-title":"Cure of Helicobacter pylori infection improves gastric acid secretion in patient with corpus gastritis","volume":"32","author":"Guttierez O","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00459.x"},{"key":"e_1_2_6_23_2","first-page":"G1159","article-title":"Influence of H. pylori infection on meal\u2010stimulated gastric acid secretion and gastroesophageal acid reflux","volume":"277","author":"Feldmann M","year":"1999","journal-title":"Am J Physiol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.2.85"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.10.10.787"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.12.1725"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03014353"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02233070","article-title":"Comparison of phenol red and polyethyleneglycol as nonabsorbable markers for the study of intestinal absorption in humans","volume":"13","author":"French AB","year":"1968","journal-title":"Am J Dig Dis"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0016-5085(19)33765-5","article-title":"Gastric nonabsorbable indicators for studies in man","volume":"59","author":"Ivey KJ","year":"1970","journal-title":"Gastroenterology"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(67)80008-8"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200502000-00010"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02272.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03592.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868110-00009"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0538-y"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.01179.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04128.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04128.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:42:32Z","timestamp":1697200952000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04128.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,20]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04128.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04128.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,20]]}}}